JNJ-7918

N/A

Report date: 2023/07/10 09:40:17
NME

Base Information

Drug NameJNJ-7918
Drug Alias NameJNJ-7918
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins inhibitors
TargetsViral hemagglutininsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A